Current Report Filing (8-k)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) 
November 10, 2016

 

ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

 

Delaware	0-19266	25-1370721
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri   (Address of principal executive offices)

63110 (Zip Code)

 

Registrant’s telephone number, including area code

[phone]

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 10, 2016. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees for Directors. The voting results are noted below.

 

ELECTION OF DIRECTORS

 

All nominees for Directors were elected with the following votes cast:

 

		For				Withheld				Broker Non-Votes
Judith T. Graves			5,182,338				86,891				1,579,368
Joseph E. Root			5,182,343				86,886				1,579,368
William A. Peck			5,180,243				88,986				1,579,368
Earl R. Refsland			5,180,766				88,763				1,579,368
John D. Weil			5,154,833				114,396				1,579,368

 

Agenda Item 2, concerning the ratification of the appointment of RubinBrown LLP as the Company’s independent registered public accounting firm for fiscal 2017 was approved by the stockholders with the following votes cast:

 

For	Against	Abstain	Broker Non-Votes
6,746,150	45,956	56,491	0

  

Agenda Item 3, an advisory (non-binding) vote to approve our executive compensation was approved by the stockholders with the following votes cast:

 

For	Against	Abstain	Broker Non-Votes
5,070,730	189,084	9,415	1,579,368

 

Agenda Item 4, a vote to approve the adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split was approved by the stockholders with the following votes cast:

  

For	Against	Abstain	Broker Non-Votes
6,171,068	418,854	3,049	255,626

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

	ALLIED HEALTHCARE PRODUCTS, INC.
	By:
Date: November 10, 2016		/s/ Daniel C. Dunn
		Daniel C. Dunn Chief Financial Officer